NCT02988635
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +23 more
- Locations
-
Not specified
Clinical trial condition
Lung Neoplasms
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
4,219 public trials
1,011 recruiting studies
Lung Neoplasms trial results
NCT00017186
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- MBCCOP - Gulf Coast Mobile, Alabama, United States
- CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
- Mayo Clinic - Jacksonville Jacksonville, Florida, United States
- CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
NCT01740804
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Guangdong general hospital Guangzhou, Guangdong, China
NCT01294306
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +19 more
- Locations
-
- Tower Cancer Research Foundation Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT02972216
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
- Locations
-
Not specified
Completed
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
NCT00154388
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
- Locations
-
Not specified
Completed
BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I
NCT00876460
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1199.29.002 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan
- 1199.29.001 Boehringer Ingelheim Investigational Site Osaka-Sayamashi, Osaka, Japan
NCT01814553
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1200.167.01009 Boehringer Ingelheim Investigational Site Santa Rosa, California, United States
- 1200.167.01020 Boehringer Ingelheim Investigational Site Orlando, Florida, United States
- 1200.167.01018 Boehringer Ingelheim Investigational Site Port Saint Lucie, Florida, United States
- 1200.167.01012 Boehringer Ingelheim Investigational Site St. Petersburg, Florida, United States
Completed
Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer
NCT01839955
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Cleveland, Ohio, United States
NCT00897442
- Conditions
- Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
- Locations
-
- Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States